Skip to main content

Gem Aromatics Q2 Net Profit Rises To ₹8.9 Crore As EBITDA Margin Expands To 12.97%

Gem Aromatics reported a 116.55% YoY increase in Q2 standalone net profit to ₹8.9 crore, driven by a 681 bps expansion in EBITDA margins to 12.97%. Standalone revenue registered a slight contraction of 6.1% YoY to ₹92.4 crore.

Author Image
Sahi Markets
Published: 31 Oct 2026, 07:38 PM IST (1 hour ago)
Last Updated: 31 Oct 2026, 07:38 PM IST (1 hour ago)
2 min read
Reviewed by Arpit Seth

Market snapshot: Gem Aromatics Limited announced its Q2 standalone financial results, delivering a net profit of ₹8.9 crore compared to ₹4.11 crore in the corresponding prior-year quarter. Operating profitability registered significant expansion, with EBITDA doubling to ₹12 crore despite a soft top-line performance.

Data Snapshot

  • Standalone Net Profit increased to ₹8.9 crore from ₹4.11 crore YoY.
  • Standalone EBITDA doubled to ₹12 crore compared to ₹6.05 crore YoY.
  • EBITDA margin widened to 12.97% from 6.16% in the previous year quarter.
  • Standalone Revenue from operations declined to ₹92.4 crore from ₹98.4 crore YoY.

What's Changed

  • Net profit increased by 116.55% YoY to ₹8.9 crore.
  • EBITDA grew by 98.35% YoY to ₹12 crore.
  • EBITDA margin expanded by 681 basis points YoY to 12.97%.
  • Revenue contracted by 6.1% YoY to ₹92.4 crore.

Key Takeaways

  • Operational efficiencies enabled robust margin enhancement despite revenue headwind.
  • Bottom-line profitability more than doubled YoY due to cost optimization and favorable margin mix.
  • Top-line revenue saw a modest 6.1% year-on-year decline.

SAHI Perspective

The operating performance reflects effective cost management and product mix enhancement. A 681 basis points expansion in EBITDA margin despite a top-line decline of 6.1% highlights improved realization per unit and operating leverage in core essential oil and specialty chemical categories.

Market Implications

The sharp expansion in operating margins is expected to provide fundamental support to stock valuation. Investors will closely track top-line trajectory in coming quarters to confirm revenue growth resumption alongside sustained profitability.

Trading Signals

Market Bias: Bullish

Directional bias is positive following strong bottom-line expansion, with standalone net profit up 116.55% YoY to ₹8.9 crore and EBITDA margins widening to 12.97%.

Overweight: Specialty Chemicals, Essential Oils & Derivatives

Trigger Factors:

  • Sustained quarterly EBITDA margin above 12%
  • Recovery in quarterly standalone revenue growth above ₹98.4 crore threshold

Time Horizon: Near-term (0-3 months)

Industry Context

Manufacturers in the specialty ingredients and essential oils domain face variable raw material procurement costs. Companies demonstrating structural margin improvement without relying solely on top-line inflation reflect stronger pricing power and operational resilience.

Key Risks to Watch

  • Top-line contraction persistence if end-user demand across personal care and oral care segments moderates.
  • Raw material price volatility in mint and eucalyptus essential oils affecting margin sustainability.

Recent Developments

In Q1 FY27, Gem Aromatics reported standalone revenue of ₹83.0 crore and net profit of ₹7.3 crore, reflecting steady operational execution. The company held its 29th Annual General Meeting on August 19, 2026.

Closing Insight

Gem Aromatics demonstrates strong bottom-line momentum with operating margins reaching 12.97%. Re-acceleration of revenue growth will be the pivotal catalyst for long-term re-rating.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics

Add Sahi as a Preferred Source on Google

Click the link, confirm the box next to sahi.com is checked — ignore any other results.